Original Source of Article: http://wp.me/p2PCVq-LX Recently, our views were published in The Economic Times regarding Monsanto’s patent rejection order passed by Intellectual Property Appellate Board (IPAB). A copy of order may be seen here: Intellectual Property Appellate Board, Chennai – Orders – Monsanto A copy of Monsanto’s International Patent publication titled “Methods for enhancing stress tolerance in … Continue reading
Article Source: http://techcorplegal.com/Blog_Technology_Law_Business_Research/2012/09/23/latest-technology-patent-trends-regenerative-medicine/ Regenerative medicine is an upcoming technology field that may be capable of repairing and replacing damaged cells, tissues, and organs by using those that are specially grown. This technology has evolved by the combined efforts of scientists belonging to a diverse range of expertise, including, biology, genetics, physiology, nanotechnology, and pharmacology. Generally, … Continue reading
Patent Expiration & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India Article Source: http://techcorplegal.com/Startup_Business/Blog/biosimilars_regulatory.html Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create … Continue reading
Patent Lawyer: Legal Expert in Protecting Technology Innovations by Patents (Role of Patent Attorney in Protection of Business Ideas & Intangible Assets) Article Source: Patent Lawyer Click Here In present economic landscape, a crucial part of business involves enduring competition by securing strong intellectual property rights. Consequently, an important factor used during the valuation of … Continue reading
The Federal Circuit on July 29, 2011, held in a 2-1 decision that isolated BRCA1/2 DNA molecules used for diagnosing increased breast and ovarian cancer risk are eligible for patent protection under 35 U.S.C. §101. Association for Molecular Pathology v. USPTO, Fed. Cir., No. 2010-1406, 7/29/2011. In addition, the panel unanimously agreed that claims on … Continue reading
The federal government can continue funding research using human embryonic stem cells, the U.S. Court of Appeals for the D.C. Circuit ruled today, reversing a lower court injunction against the National Institutes of Health. Two scientists who work with adult stem cells sued NIH to stop embryonic stem cell research, charging that revised 2009 guidelines … Continue reading
